Company profile

SVA

Sinovac Biotech Ltd.

NASDAQHealthcare

End-of-day prices provided by Twelve Data · One close per session. Not real time and not a quote.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

Declared intent to influence

Filed on Schedule 13D: the investor states an intention to influence how the company is run.

1Globe Capital LLC32.3%Sep 10, 25SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
SAIF Partners IV L.P.15.0%Dec 15, 25SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings
Weidong Yin8.8%Jul 10, 25SCHEDULE 13D/A ↗2 earlier filings
Advantech Capital L.P.8.1%Jul 8, 25SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
Vivo Capital IX, LLC6.3%Jul 11, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

554 filings on record, the oldest from Oct 26, 00.

4 6-K filingsshow all 4hide
- Aug 17, 266-K ↗
- Jul 15, 266-K ↗
- Jun 15, 266-K ↗
- Jun 5, 266-K ↗
Jun 5, 2620-F ↗

Beta

Scores, historical analogues, watchlist and Radar work over the same companies you can already browse here.

Invite-only beta. Payments are not active yet.